Cohance Lifesciences Limited — Others, 28-03-2025: Resignation

Mr. Subba Raju Komaravolu has resigned from his position as Chief Strategy Officer at Suven Pharmaceuticals, effective at the close of working hours on March 31, 2025. This transition appears to be due to personal reasons, as highlighted in his resignation letter. His departure may necessitate adjustments in the company's strategic initiatives, including ongoing projects like the Disha program. Investors should monitor this leadership change closely, as it may impact the company’s strategic direction, but the overall sentiment remains stable for now.